Technology or method
Recombinant DNA
DNA joined from different sources, the starting point of genetic engineering and of medicines such as recombinant insulin.
Risk-based practices and containment that protect people and the environment when working with biological agents.Source: WHO, 2020Source: CDCSource: Berg et al., 1975
Technology or method
DNA joined from different sources, the starting point of genetic engineering and of medicines such as recombinant insulin.
Technology or method
Designing and building new biological parts, circuits and systems.
Ethics and safety
Weighing the benefits, risks and fairness of biological research and its uses.
The explanations on this page are our own summaries of these sources. Follow a link to read the original; if anything here disagrees with it, the original wins. How we choose and check sources.
World Health Organization (2020). WHO publications. World Health Organization. Published 2020-12-21.
Centers for Disease Control and Prevention, National Institutes of Health. CDC Laboratories. U.S. Department of Health and Human Services.
The U.S. reference for laboratory biosafety practice.
Berg P, Baltimore D, Brenner S, et al. (1975). Proceedings of the National Academy of Sciences 72:1981-1984.
Scientists' own guidelines for the safe conduct of recombinant DNA research.